Bali Zero
  • Home
  • Visa
  • Tax
  • Property
Get Started
KBLI Navigator/Section C/21022
KBLI 21022

Herbal Medicine Product Manufacturing, Human

Industri Produk Obat Bahan Alam untuk Manusia

🏭 Section C — Manufacturing

Closed to PMA (national)

Instrument locator: Perpres 49/2021 Lampiran II (Koperasi/UMKM) + Lampiran III (foreign ownership)

🚫Closed· 0% foreign ownershipHigh RiskDirect Match🏝️✅Registrable in Bali· medium conf.OSS risk at scale Besar is Menengah-Tinggi/Tinggi → not blocked by moratorium✓OSS-verified · KBLI 2025

Natural-Medicine Manufacturing — Reserved for Domestic Capital, No PMA Route

KBLI 21022 covers human natural-medicine product manufacturing. The national record reserves it for domestic capital — a PT PMA cannot register this activity, in Bali or anywhere else in Indonesia.

By the numbers
National PMA status
TERBATAS
Foreign ownership ceiling
0%
Open scales
Mikro, Kecil, Menengah, Besar
Bali status
Registrable in Bali
Based only on this record, KBLI 21022 is reserved for domestic capital nationwide — the PT PMA route is unavailable, in Bali and everywhere else in Indonesia.
What Changed

Direct 1:1 match from KBLI 2020 — code and scope unchanged.

What You Need

Nationally, the foreign-ownership ceiling is 0% — Perpres 10/2021 as amended by 49/2021 reserves this activity for domestic capital (Lampiran III entry #6), presumed to carry over from the KBLI 2020 code this one renamed (UU 17/2023; no contrary OSS/BKPM guidance found). In Bali, it’s not blocked by the local moratorium, but it falls into medium-high to high risk, so approval will depend on a per-address verification (location and compliance check) — a PT PMA route is not available regardless.

Who This Is For

Foreign entrepreneurs who want to produce herbal remedies, traditional jamu, or natural health supplements in Bali.

Licensing Overview
Risk LevelTinggi
License TypeNIB + Izin
Foreign OwnershipClosed (0%)
Processing7 working days
Authoritative BPS crosswalk
Official BPS 2020 → 2025 crosswalk ancestors: 21022

Source: the BPS 2020↔2025 conversion table, mechanically extracted and acceptance-gate verified. It shows which 2020 codes map to this 2025 code — provenance only, not a licensing claim: the regulatory regime of these predecessor codes has not been adjudicated as transferring.

PP 28/2025 licensing source
PP 28/2025 licensing-source codes (KBLI 2020 numbering): 21022

These codes identify the PP 28/2025 regulatory rows used as licensing sources for this page. They are not the official BPS 2020 → 2025 crosswalk and do not establish predecessor ancestry.

Sources & Verification

Each data layer below traces to a government source with its KBLI vintage — or is declared as a gap. Nothing in these layers is silently filled in.

Activity definition
BPS Peraturan 7/2025 + PP 28/2025VerifiedKBLI 2025

Title and scope as defined by the KBLI-2025 classification.

locator: OSS_RBA_2025_id_version_fff4053d

Risk & licensing
OSS RBA risk scope (ruang lingkup)VerifiedKBLI 2025

Risk category and licensing rows are KBLI-2025-native from the OSS Risk-Based Approach catalog.

locator: OSS_RBA_resiko_2025

Foreign ownership (PMA)
Perpres 10/2021, 49/2021Verified2021-05-25

The current whole-code foreign-ownership verdict has an adjudicated official basis and source vintage in the canonical record.

locator: Perpres 49/2021 Lampiran III (Daftar Bidang Usaha dengan Persyaratan Tertentu) entry #6

Bali status
Bali province blocks ALL Low + Medium-Low risk KBLI for PMA (island-wide, permanent) (effective 2026-05-13)Audit pending2026 overlay

Conservative posture derived from the risk tier · confidence MEDIUM.

Dataset last updated 2026-08-15 · KBLI 2020 and KBLI 2025 reuse code numbers for different activities — cross-vintage rows are labeled, never merged silently.

Common Questions
Can foreigners operate a herbal medicine product manufacturing, human business in Indonesia?
No. KBLI 21022 (Industri Produk Obat Bahan Alam untuk Manusia) is TERBATAS, but the ceiling for foreign capital is 0% — in practice the activity is not available to a PT PMA and is held by an Indonesian-owned company. Condition: Modal dalam negeri 100% — open to domestic capital only. (Source: Perpres 10/2021, 49/2021.)
What license is required for KBLI 21022?
KBLI 21022 has a Tinggi risk classification. Required license: NIB + Izin. Processing time: 7.
What is KBLI 21022?
KBLI 21022 is the Indonesian business classification code for "Industri Produk Obat Bahan Alam untuk Manusia" (Herbal Medicine Product Manufacturing, Human). It falls under Section C of KBLI 2025, the Indonesian Standard Industrial Classification updated by BPS (Regulation 7/2025). The June 2026 KBLI 2025 transition window has closed; operators should verify the code's current OSS/NIB treatment before relying on it for licensing, reporting, or amendments.
How did KBLI 21022 change from KBLI 2020 to 2025?
According to the official BPS 2020 → 2025 crosswalk, KBLI 21022 has recorded KBLI 2020 ancestor(s) 21022. This is provenance only, not a licensing claim; no predecessor licensing regime is asserted to transfer. The June 2026 KBLI 2025 transition window has closed. If an NIB still relies on legacy KBLI 2020 mappings, treat the migration as overdue and verify/remediate the OSS record before new license applications, amendments, LKPM, import approvals, or investor/worker sponsorship.

Related Codes

21023Section C

Herbal Medicine Product Manufacturing, Veterinary

Industri Produk Obat Bahan Alam untuk Hewan

→
❓PMA unverifiedMedium-Low Risk
21021Section C

Herbal Medicine Raw Material Manufacturing, Human

Industri Bahan Baku Obat Bahan Alam untuk Manusia

→
🏝️✅Registrable in Bali🚫Closed· 0% foreign ownershipHigh Risk
21024Section C

Herbal Medicine Raw Material Manufacturing, Veterinary

Industri Bahan Baku Obat Bahan Alam untuk Hewan

→
❓PMA unverifiedHigh Risk
21015Section C

Medical Diagnostics, Bandages & Health Support Devices

Industri Alat Diagnosis Medis, Perban, Kasa, dan Penunjang Kesehatan Lainnya

→
❓PMA unverifiedHigh Risk
21014Section C

Veterinary Pharmaceutical Raw Material Manufacturing

Industri Bahan Baku Farmasi untuk Hewan

→
❓PMA unverifiedMedium-High Risk
21013Section C

Veterinary Pharmaceutical Product Manufacturing

Industri Produk Farmasi untuk Hewan

→
❓PMA unverifiedMedium-Low Risk
🏢

Ready to register this business?

Bali Zero handles company setup, KBLI registration, NIB, and licensing for KBLI 21022.

PT PMA Setup

IDR 20.000.000

Company registration, KBLI, NIB, domicile

Virtual Office

IDR 5.000.000

Legal address for your company in Bali

5,000+ companies registered since 2020

Get started on WhatsApp
5k+
Clients
★ 4.9
Rating
693
Google reviews
Talk on WhatsApp
Zantara AIOSS Intelligence System
Context21022
Ask me about KBLI 21022: its official scope, licensing, risk, or foreign-ownership verification.